Trials / Completed
CompletedNCT00359112
AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes
A Randomised, Multi-Centre, Phase IV, Double-Blind, Parallel Group Study Comparing the Effects of 52 Weeks Administration of AVANDAMET and Metformin Plus Sulphonylurea on Change in HbA1c From Baseline in Overweight Type 2 Diabetics Poorly Controlled on Metformin.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 544 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the effects of Avandamet (rosiglitazone maleate/metformin) treatment and metformin plus sulphonylurea treatment in overweight people with type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | metformin | |
| DRUG | sulphonylurea | |
| DRUG | Avandamet |
Timeline
- Start date
- 2004-02-01
- First posted
- 2006-08-01
- Last updated
- 2009-05-18
Locations
142 sites across 11 countries: Belgium, France, Germany, Ireland, Italy, Lithuania, Mexico, Netherlands, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00359112. Inclusion in this directory is not an endorsement.